Endovascular Treatment of Descending Thoracic Aortic Pathology: Results of the Regis-TEVAR Study

•The first Spanish multicenter registry on endovascular treatment of thoracic aortic disease.•Reliable information on real-world clinical practice of TEVAR.•Indication distribution: 54% thoracic aortic aneurysm, 31.4% type B aortic dissections, and 12.5% traumatic aortic injuries.•The overall mortality was 11.9%, higher (18.5%) if the repair was urgent.•Low-stroke rate (3.1%) and spinal cord ischemia (4.9%).•TEVAR can be performed with acceptable morbidity and mortality and with low rates of postoperative complications.